Cargando…

Suicidality in Treatment-Resistant Depression Patients

INTRODUCTION: Depression and treatment-resistant depression (RD) are associated with suicidal behavior (SB) at a higher rate. OBJECTIVES: 1) determination prevalence of RD in district outpatient psychiatric сlinics (i.e., dispensaries) and the socio-demographic characteristics of RD patients with SB...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyubov, E. B., Semenova, N. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434094/
http://dx.doi.org/10.1192/j.eurpsy.2023.704
_version_ 1785091803257503744
author Lyubov, E. B.
Semenova, N. D.
author_facet Lyubov, E. B.
Semenova, N. D.
author_sort Lyubov, E. B.
collection PubMed
description INTRODUCTION: Depression and treatment-resistant depression (RD) are associated with suicidal behavior (SB) at a higher rate. OBJECTIVES: 1) determination prevalence of RD in district outpatient psychiatric сlinics (i.e., dispensaries) and the socio-demographic characteristics of RD patients with SB. METHODS: In this multicenter (3 sites), retrospective, observational epidemiological study, patients (n=148) with diagnoses F 30-39 (ICD-10) were recruited in 2020. Patients (n=22) were assessed for RD, defined as failure to respond to ≥ two antidepressant medications of adequate dose and duration for at least three months. RESULTS: The prevalence of depression is ≤ 2% of the outpatient population. RD prevalence ˜15%. SB (i.e., suicidal attempts) was noted in every fifth (n=5) for the index year. SB patients differed in the following typical features: a woman (82%) mean age, 46.8 years with long-term (≥ 10 years) depression and annual hospitalizations for three years (61.4 days per patient), and with suicidal attempts (repeated within the last two years) through (80%) self-poisoning with psychotropic drugs. Nobоdy worked, and everyone was divorced. CONCLUSIONS: On the background of ubiquitous underdiagnosis of depressive disorders in routine practice, RD patients with SP represent a high-resource users group with combined clinical and social problems requiring pharmacotherapy and target psychosocial rehabilitation. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10434094
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104340942023-08-18 Suicidality in Treatment-Resistant Depression Patients Lyubov, E. B. Semenova, N. D. Eur Psychiatry Abstract INTRODUCTION: Depression and treatment-resistant depression (RD) are associated with suicidal behavior (SB) at a higher rate. OBJECTIVES: 1) determination prevalence of RD in district outpatient psychiatric сlinics (i.e., dispensaries) and the socio-demographic characteristics of RD patients with SB. METHODS: In this multicenter (3 sites), retrospective, observational epidemiological study, patients (n=148) with diagnoses F 30-39 (ICD-10) were recruited in 2020. Patients (n=22) were assessed for RD, defined as failure to respond to ≥ two antidepressant medications of adequate dose and duration for at least three months. RESULTS: The prevalence of depression is ≤ 2% of the outpatient population. RD prevalence ˜15%. SB (i.e., suicidal attempts) was noted in every fifth (n=5) for the index year. SB patients differed in the following typical features: a woman (82%) mean age, 46.8 years with long-term (≥ 10 years) depression and annual hospitalizations for three years (61.4 days per patient), and with suicidal attempts (repeated within the last two years) through (80%) self-poisoning with psychotropic drugs. Nobоdy worked, and everyone was divorced. CONCLUSIONS: On the background of ubiquitous underdiagnosis of depressive disorders in routine practice, RD patients with SP represent a high-resource users group with combined clinical and social problems requiring pharmacotherapy and target psychosocial rehabilitation. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434094/ http://dx.doi.org/10.1192/j.eurpsy.2023.704 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Lyubov, E. B.
Semenova, N. D.
Suicidality in Treatment-Resistant Depression Patients
title Suicidality in Treatment-Resistant Depression Patients
title_full Suicidality in Treatment-Resistant Depression Patients
title_fullStr Suicidality in Treatment-Resistant Depression Patients
title_full_unstemmed Suicidality in Treatment-Resistant Depression Patients
title_short Suicidality in Treatment-Resistant Depression Patients
title_sort suicidality in treatment-resistant depression patients
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434094/
http://dx.doi.org/10.1192/j.eurpsy.2023.704
work_keys_str_mv AT lyuboveb suicidalityintreatmentresistantdepressionpatients
AT semenovand suicidalityintreatmentresistantdepressionpatients